PROCEPT BioRobotics Corp (PRCT)
97.07
+4.78
(+5.18%)
USD |
NASDAQ |
Nov 04, 16:00
97.10
+0.03
(+0.03%)
Pre-Market: 09:00
PROCEPT BioRobotics Revenue (Quarterly): 58.37M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 58.37M |
| June 30, 2024 | 53.35M |
| March 31, 2024 | 44.54M |
| December 31, 2023 | 43.58M |
| September 30, 2023 | 35.10M |
| June 30, 2023 | 33.10M |
| March 31, 2023 | 24.40M |
| December 31, 2022 | 23.78M |
| September 30, 2022 | 20.35M |
| Date | Value |
|---|---|
| June 30, 2022 | 16.69M |
| March 31, 2022 | 14.20M |
| December 31, 2021 | 10.14M |
| September 30, 2021 | 8.668M |
| June 30, 2021 | 8.476M |
| March 31, 2021 | 7.192M |
| December 31, 2020 | 3.221M |
| September 30, 2020 | 2.107M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.107M
Minimum
Sep 2020
58.37M
Maximum
Sep 2024
23.96M
Average
20.35M
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Teleflex Inc | 764.38M |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 29.94M |
| Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.97M |
| Total Expenses (Quarterly) | 80.80M |
| EPS Diluted (Quarterly) | -0.40 |
| Enterprise Value | 5.107B |
| Gross Profit Margin (Quarterly) | 63.24% |
| Profit Margin (Quarterly) | -35.93% |
| Earnings Yield | -2.01% |
| Normalized Earnings Yield | -2.009 |